The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Aurora‐A Kinase: A Potent Oncogene and Target for Cancer Therapy
Abstract
The Aurora kinase family is comprised of three serine/threonine kinases, Aurora‐A, Aurora‐B, and Aurora‐C. Among these, Aurora‐A and Aurora‐B play central roles in mitosis, whereas Aurora‐C executes unique roles in meiosis. Overexpression or gene amplification of Aurora kinases has been reported in a broad range of human malignancies, pointing to their role as potent oncogenes in tumorigenesis. Aurora kinases therefore represent promising targets for anticancer therapeutics. A number of Aurora kinase inhibitors (AKIs) have been generated; some of which are currently undergoing clinical evaluation. Recent studies have unveiled novel unexpected functions of Aurora kinases during cancer development and the mechanisms underlying the anticancer actions of AKIs. In this review, we discuss the most recent advances in Aurora‐A kinase research and targeted cancer therapy, focusing on the oncogenic roles and signaling pathways of Aurora‐A kinases in promoting tumorigenesis, the recent preclinical and clinical AKI data, and potential alternative routes for Aurora‐A kinase inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
BRCA1 Phosphorylation by Aurora-A in the Regulation of G2 to M Transition
Ouchi, M., Fujiuchi, N., Sasai, K., Katayama, H., Minamishima, Y. A., Ongusaha, P. P., Deng, C., Sen, S., Lee, S. W., & Ouchi, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311780200 · Cited by 199
RetractedZheng, X., Guo, J. P., Yang, H., Kanai, M., He, L., Li, Y., Koomen, J. M., Minton, S., Gao, M., Ren, X. B., et al. (2013) · Oncogene · doi:10.1038/onc.2013.444 · Cited by 39
RetractedMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
Zhou, H., Kuang, J., Zhong, L., Kuo, W.-L., Gray, J., Sahin, A., Brinkley, B., & Sen, S. (1998) · Nature Genetics · doi:10.1038/2496 · Cited by 1,276
The cellular geography of Aurora kinases
Carmena, M., & Earnshaw, W. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1245 · Cited by 1,139
Nuclear localization of EGF receptor and its potential new role as a transcription factor
Lin, S.-Y., Makino, K., Xia, W., Matin, A., Wen, Y., Kwong, K. Y., Bourguignon, L., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/ncb0901-802 · Cited by 1,064
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Yang, W., Xia, Y., Ji, H., Zheng, Y., Liang, J., Huang, W., Gao, X., Aldape, K., & Lu, Z. (2011) · Nature · doi:10.1038/nature10598 · Cited by 1,028
Harrington, E. A., Bebbington, D., Moore, J., Rasmussen, R. K., Ajose-Adeogun, A. O., Nakayama, T., Graham, J. A., Demur, C., Hercend, T., Diu-Hercend, A., et al. (2004) · Nature Medicine · doi:10.1038/nm1003 · Cited by 965
The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis
Carmena, M., Wheelock, M., Funabiki, H., & Earnshaw, W. C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3474 · Cited by 905
HEF1-Dependent Aurora A Activation Induces Disassembly of the Primary Cilium
Pugacheva, E. N., Jablonski, S. A., Hartman, T. R., Henske, E. P., & Golemis, E. A. (2007) · Cell · doi:10.1016/j.cell.2007.04.035 · Cited by 890
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
O'Farrell, A.-M., Abrams, T. J., Yuen, H. A., Ngai, T. J., Louie, S. G., Yee, K. W. H., Wong, L. M., Hong, W., Lee, L. B., Town, A., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2307 · Cited by 864
Chromosomal passengers: conducting cell division
Ruchaud, S., Carmena, M., & Earnshaw, W. C. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2257 · Cited by 811
Aurora-A — A guardian of poles
Marumoto, T., Zhang, D., & Saya, H. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1526 · Cited by 697
Proteomic Screen Finds pSer/pThr-Binding Domain Localizing Plk1 to Mitotic Substrates
Elia, A. E. H., Cantley, L. C., & Yaffe, M. B. (2003) · Science · doi:10.1126/science.1079079 · Cited by 684
Aurora-kinase inhibitors as anticancer agents
Keen, N., & Taylor, S. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1502 · Cited by 675
Anand, S., Penrhyn-Lowe, S., & Venkitaraman, A. R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00235-0 · Cited by 631
Hirota, T., Kunitoku, N., Sasayama, T., Marumoto, T., Zhang, D., Nitta, M., Hatakeyama, K., & Saya, H. (2003) · Cell · doi:10.1016/s0092-8674(03)00642-1 · Cited by 628
Bora and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and Control Mitotic Entry
Seki, A., Coppinger, J. A., Jang, C.-Y., Yates, J. R., & Fang, G. (2008) · Science · doi:10.1126/science.1157425 · Cited by 619
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
Katayama, H., Sasai, K., Kawai, H., Yuan, Z.-M., Bondaruk, J., Suzuki, F., Fujii, S., Arlinghaus, R. B., Czerniak, B. A., & Sen, S. (2004) · Nature Genetics · doi:10.1038/ng1279 · Cited by 588
Human TPX2 is required for targeting Aurora-A kinase to the spindle
Kufer, T. A., Silljé, H. H. W., Körner, R., Gruss, O. J., Meraldi, P., & Nigg, E. A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204155 · Cited by 587
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
Otto, T., Horn, S., Brockmann, M., Eilers, U., Schüttrumpf, L., Popov, N., Kenney, A. M., Schulte, J. H., Beijersbergen, R., Christiansen, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.005 · Cited by 573
ConsensusPathDB--a database for integrating human functional interaction networks
Kamburov, A., Wierling, C., Lehrach, H., & Herwig, R. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn698 · Cited by 565
Sen, S., Zhou, H., & White, R. A. (1997) · Oncogene · doi:10.1038/sj.onc.1201065 · Cited by 482
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
Manfredi, M. G., Ecsedy, J. A., Meetze, K. A., Balani, S. K., Burenkova, O., Chen, W., Galvin, K. M., Hoar, K. M., Huck, J. J., LeRoy, P. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608798104 · Cited by 413
Polo-like Kinase-1 Controls Recovery from a G2 DNA Damage-Induced Arrest in Mammalian Cells
van Vugt, M. A. T. M., Brás, A., & Medema, R. H. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.015 · Cited by 385
A Novel Mechanism for Activation of the Protein Kinase Aurora A
Eyers, P. A., Erikson, E., Chen, L. G., & Maller, J. L. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00166-0 · Cited by 369
Wirtz-Peitz, F., Nishimura, T., & Knoblich, J. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.049 · Cited by 369
Aurora-A Kinase Maintains the Fidelity of Early and Late Mitotic Events in HeLa Cells
Marumoto, T., Honda, S., Hara, T., Nitta, M., Hirota, T., Kohmura, E., & Saya, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306275200 · Cited by 362
Aurora-A Abrogation of p53 DNA Binding and Transactivation Activity by Phosphorylation of Serine 215
Liu, Q., Kaneko, S., Yang, L., Feldman, R. I., Nicosia, S. V., Chen, J., & Cheng, J. Q. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406802200 · Cited by 334
Self-citationHoward, S., Berdini, V., Boulstridge, J. A., Carr, M. G., Cross, D. M., Curry, J., Devine, L. A., Early, T. R., Fazal, L., Gill, A. L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm800984v · Cited by 333
Ewart-Toland, A., Briassouli, P., de Koning, J. P., Mao, J.-H., Yuan, J., Chan, F., MacCarthy-Morrogh, L., Ponder, B. A. J., Nagase, H., Burn, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1220 · Cited by 320
A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis
Kollmann, K., Heller, G., Schneckenleithner, C., Warsch, W., Scheicher, R., Ott, R. G., Schäfer, M., Fajmann, S., Schlederer, M., Schiefer, A.-I., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.012 · Cited by 313
Littlepage, L. E., & Ruderman, J. V. (2002) · Genes & Development · doi:10.1101/gad.1007302 · Cited by 308
Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer.
Gritsko, T. M., Coppola, D., Paciga, J. E., Yang, L., Sun, M., Shelley, S. A., Fiorica, J. V., Nicosia, S. V., & Cheng, J. Q. (2003) · PubMed · Cited by 303
Manfredi, M. G., Ecsedy, J. A., Chakravarty, A., Silverman, L., Zhang, M., Hoar, K. M., Stroud, S. G., Chen, W., Shinde, V., Huck, J. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1536 · Cited by 300
Brockmann, M., Poon, E., Berry, T., Carstensen, A., Deubzer, H. E., Rycak, L., Jamin, Y., Thway, K., Robinson, S. P., Roels, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.005 · Cited by 299
Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2–M transition
Dutertre, S., Cazales, M., Quaranta, M., Froment, C., Trabut, V., Dozier, C., Mirey, G., Bouché, J.-P., Theis-Febvre, N., Schmitt, E., et al. (2004) · Journal of Cell Science · doi:10.1242/jcs.01108 · Cited by 284
Control of the G2/M Transition
Stark, G. R., & Taylor, W. R. (2006) · Molecular Biotechnology · doi:10.1385/mb:32:3:227 · Cited by 279
Drugging MYCN through an Allosteric Transition in Aurora Kinase A
Gustafson, W. C., Meyerowitz, J. G., Nekritz, E. A., Chen, J., Benes, C., Charron, E., Simonds, E. F., Seeger, R., Matthay, K. K., Hertz, N. T., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.015 · Cited by 278
Young, M. A., Shah, N. P., Chao, L. H., Seeliger, M., Milanov, Z. V., Biggs, W. H., Treiber, D. K., Patel, H. K., Zarrinkar, P. P., Lockhart, D. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2788 · Cited by 276
Görgün, G., Calabrese, E., Hideshima, T., Ecsedy, J., Perrone, G., Mani, M., Ikeda, H., Bianchi, G., Hu, Y., Cirstea, D., et al. (2010) · Blood · doi:10.1182/blood-2009-12-259523 · Cited by 274
Aurora-A acts as a tumor suppressor and regulates self-renewal of Drosophila neuroblasts
Wang, H., Somers, G. W., Bashirullah, A., Heberlein, U., Yu, F., & Chia, W. (2006) · Genes & Development · doi:10.1101/gad.1487506 · Cited by 268
Lee, C.-Y., Andersen, R. O., Cabernard, C., Manning, L., Tran, K. D., Lanskey, M. J., Bashirullah, A., & Doe, C. Q. (2006) · Genes & Development · doi:10.1101/gad.1489406 · Cited by 259
Melichar, B., Adenis, A., Lockhart, A. C., Bennouna, J., Dees, E. C., Kayaleh, O., Obermannova, R., DeMichele, A., Zatloukal, P., Zhang, B., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70051-3 · Cited by 254
Kinoshita, K., Noetzel, T. L., Pelletier, L., Mechtler, K., Drechsel, D. N., Schwager, A., Lee, M., Raff, J. W., & Hyman, A. A. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503023 · Cited by 253
Mosquera, J. M., Beltran, H., Park, K., MacDonald, T. Y., Robinson, B. D., Tagawa, S. T., Perner, S., Bismar, T. A., Erbersdobler, A., Dhir, R., et al. (2013) · Neoplasia · doi:10.1593/neo.121550 · Cited by 249
Kunitoku, N., Sasayama, T., Marumoto, T., Zhang, D., Honda, S., Kobayashi, O., Hatakeyama, K., Ushio, Y., Saya, H., & Hirota, T. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00364-2 · Cited by 248
Carpinelli, P., Ceruti, R., Giorgini, M. L., Cappella, P., Gianellini, L., Croci, V., Degrassi, A., Texido, G., Rocchetti, M., Vianello, P., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0444 · Cited by 245
den Hollander, J., Rimpi, S., Doherty, J. R., Rudelius, M., Buck, A., Hoellein, A., Kremer, M., Graf, N., Scheerer, M., Hall, M. A., et al. (2010) · Blood · doi:10.1182/blood-2009-11-251074 · Cited by 242
Aurora kinase inhibitors: Progress towards the clinic
Kollareddy, M., Zheleva, D., Dzubak, P., Brahmkshatriya, P. S., Lepsik, M., & Hajduch, M. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9798-6 · Cited by 242
Aurora kinases and protein phosphatase 1 mediate chromosome congression through regulation of CENP-E
Kim, Y., Holland, A. J., Lan, W., & Cleveland, D. W. (2010) · Cell · doi:10.1016/j.cell.2010.06.039 · Cited by 233
Maris, J. M., Morton, C. L., Gorlick, R., Kolb, E. A., Lock, R., Carol, H., Keir, S. T., Reynolds, C. P., Kang, M. H., Wu, J., et al. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22430 · Cited by 226
Giet, R., Uzbekov, R., Cubizolles, F., Le Guellec, K., & Prigent, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15005 · Cited by 219
Friedberg, J. W., Mahadevan, D., Cebula, E., Persky, D., Lossos, I., Agarwal, A. B., Jung, J., Burack, R., Zhou, X., Leonard, E. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.8793 · Cited by 212
Zheng, F., Yue, C., Li, G., He, B., Cheng, W., Wang, X., Yan, M., Long, Z., Qiu, W., Yuan, Z., et al. (2016) · Nature Communications · doi:10.1038/ncomms10180 · Cited by 197
Self-citationReiter, R., Gais, P., Jütting, U., Steuer-Vogt, M. K., Pickhard, A., Bink, K., Rauser, S., Lassmann, S., Höfler, H., Werner, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1650 · Cited by 189
Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells
Zou, Z., Yuan, Z., Zhang, Q., Long, Z., Chen, J., Tang, Z., Zhu, Y., Chen, S., Xu, J., Yan, M., et al. (2012) · Autophagy · doi:10.4161/auto.22110 · Cited by 181
Self-citationPlotnikova, O. V., Nikonova, A. S., Loskutov, Y. V., Kozyulina, P. Y., Pugacheva, E. N., & Golemis, E. A. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-12-1056 · Cited by 176
Pitchfork Regulates Primary Cilia Disassembly and Left-Right Asymmetry
Kinzel, D., Boldt, K., Davis, E. E., Burtscher, I., Trümbach, D., Diplas, B. H., Attié‐Bitach, T., Wurst, W., Katsanis, N., Ueffing, M., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.005 · Cited by 169
Gontarewicz, A., Balabanov, S., Keller, G., Colombo, R., Graziano, A., Pesenti, E., Benten, D., Bokemeyer, C., Fiedler, W., Moll, J., et al. (2008) · Blood · doi:10.1182/blood-2007-09-113175 · Cited by 165
Barros, T. P., Kinoshita, K., Hyman, A. A., & Raff, J. W. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504097 · Cited by 165
Yang, H., He, L., Kruk, P. A., Nicosia, S. V., & Cheng, J. Q. (2006) · International Journal of Cancer · doi:10.1002/ijc.22154 · Cited by 164
Cyclin B2 and p53 control proper timing of centrosome separation
Nam, H.-J., & van Deursen, J. M. (2014) · Nature Cell Biology · doi:10.1038/ncb2952 · Cited by 161
Trichoplein and Aurora A block aberrant primary cilia assembly in proliferating cells
Inoko, A., Matsuyama, M., Goto, H., Ohmuro-Matsuyama, Y., Hayashi, Y., Enomoto, M., Ibi, M., Urano, T., Yonemura, S., Kiyono, T., et al. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201106101 · Cited by 161
Dees, E. C., Cohen, R. B., von Mehren, M., Stinchcombe, T. E., Liu, H., Venkatakrishnan, K., Manfredi, M. G., Fingert, H. J., Burris, H. A., & Infante, J. R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0589 · Cited by 159
Tong, T., Zhong, Y., Kong, J., Dong, L., Song, Y., Fu, M., Liu, Z., Wang, M., Guo, L., Lu, S., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0806 · Cited by 159
Cammareri, P., Scopelliti, A., Todaro, M., Eterno, V., Francescangeli, F., Moyer, M. P., Agrusa, A., Dieli, F., Zeuner, A., & Stassi, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3953 · Cited by 159
Smith, S. L., Bowers, N. L., Betticher, D. C., Gautschi, O. P., Ratschiller, D., Hoban, P. R., Booton, R., Santibanez‐Koref, M., & Heighway, J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602779 · Cited by 154
Cervantes, A. M. R., Élez, E., Roda, D., Ecsedy, J., Macarulla, T. M., Venkatakrishnan, K., Roselló, S., Andreu, J., Jung, J., Sanchis, J. M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0571 · Cited by 153
Cell division: control of the chromosomal passenger complex in time and space
van der Horst, A., & Lens, S. M. A. (2013) · Chromosoma · doi:10.1007/s00412-013-0437-6 · Cited by 147
Synthetic Lethal Screen of an EGFR-Centered Network to Improve Targeted Therapies
Astsaturov, I. A., Ratushny, V., Sukhanova, A. L., Einarson, M. B., Bagnyukova, T., Zhou, Y., Devarajan, K., Silverman, J. S., Tikhmyanova, N., Skobeleva, N., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2001083 · Cited by 144
Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer
Nadler, Y., Camp, R. L., Schwartz, C., Rimm, D. L., Kluger, H. M., & Kluger, Y. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5268 · Cited by 143
Huang, X.-F., Luo, S.-K., Xu, J., Li, J., Xu, D.-R., Wang, L., Yan, M., Wang, X.-R., Wan, X., Zheng, F.-M., et al. (2007) · Blood · doi:10.1182/blood-2007-07-099325 · Cited by 139
Self-citationFletcher, G. C., Brokx, R. D., Denny, T. A., Hembrough, T., Plum, S. M., Fogler, W. E., Sidor, C. F., & Bray, M. R. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0574 · Cited by 134
Matulonis, U. A., Sharma, S. K., Ghamande, S., Gordon, M. S., Prete, S. A. D., Ray-Coquard, I. L., Kutarska, E., Liu, H., Fingert, H. J., Zhou, X., et al. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.06.040 · Cited by 133
Regulation of Xenopus Aurora A Activation by TPX2
Eyers, P. A., & Maller, J. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312424200 · Cited by 133
Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion
Do, T.-V., Xiao, F., Bickel, L. E., Klein–Szanto, A. J., Pathak, H. B., Hua, X., Howe, C. G., O’Brien, S. W., Maglaty, M. A., Ecsedy, J., et al. (2013) · Oncogene · doi:10.1038/onc.2012.632 · Cited by 131
APC/CCdh1 Targets Aurora Kinase to Control Reorganization of the Mitotic Spindle at Anaphase
Floyd, S., Pines, J., & Lindon, C. (2008) · Current Biology · doi:10.1016/j.cub.2008.09.058 · Cited by 131
Tanaka, E. I., Hashimoto, Y., Ito, T., Okumura, T., Kan, T., Watanabe, G., Imamura, M., Inazawa, J., & Shimada, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1627 · Cited by 130
Wang, L., Xiang, J., Yan, M., Zhang, Y., Zhao, Y., Yue, C.-F., Xu, J., Zheng, F.-M., Chen, J.-N., Kang, Z., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1246 · Cited by 130
Self-citationPayton, M. N., Bush, T. L., Chung, G., Ziegler, B., Eden, P., McElroy, P. L., Ross, S. L., Cee, V. J., Deak, H. L., Hodous, B. L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-3001 · Cited by 128
Vischioni, B., Oudejans, J. J., Vos, W., Rodríguez, J. A., & Giaccone, G. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0301 · Cited by 128
Guan, Z., Wang, X.-R., Zhu, X., Huang, X.-F., Xu, J., Wang, L., Wan, X., Long, Z., Liu, J.-N., Feng, G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1379 · Cited by 128
Self-citationYang, G. S., Chang, B., Yang, F., Guo, X. Q., Cai, K. Q., Xiao, X., Wang, H., Sen, S., Hung, M., Mills, G. B., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3171 · Cited by 128
D’Assoro, A. B., Liu, T., Quatraro, C., Amato, A. M., Opyrchal, M., Leontovich, A. A., Ikeda, Y., Ohmine, S., Lingle, W. L., Suman, V. J., et al. (2013) · Oncogene · doi:10.1038/onc.2012.628 · Cited by 124
Aurora A, mitotic entry, and spindle bipolarity
Liu, Q., & RUDERMAN, J. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601425103 · Cited by 122
Self-citationA Microtubule-Independent Role for Centrosomes and Aurora A in Nuclear Envelope Breakdown
Portier, N., Audhya, A., Maddox, P. S., Green, R. A., Dammermann, A., Desai, A. B., & Oegema, K. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.01.019 · Cited by 120
Sloane, D. A., Trikić, M. Z., Chu, M. L.-H., Lamers, M., Mason, C., Müller, I., Savory, W. J., Williams, D. H., & Eyers, P. A. (2010) · ACS Chemical Biology · doi:10.1021/cb100053q · Cited by 120
Huck, J. J., Zhang, M., McDonald, A. A., Bowman, D., Hoar, K. M., Stringer, B., Ecsedy, J. A., Manfredi, M. G., & Hyer, M. L. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0300 · Cited by 120
Mossé, Y. P., Lipsitz, E. G., Fox, E., Teachey, D. T., Maris, J. M., Weigel, B. J., Adamson, P. C., Ingle, M. A., Ahern, C. H., & Blaney, S. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3251 · Cited by 120
Gowrikumar, S., Palanivel, C., Manikandan, R., & Sudhandiran, G. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.013 · Cited by 119
Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme
Zeng, W., Navaratne, K., Prayson, R. A., & Weil, R. J. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.036806 · Cited by 117
Aurora Kinase A Promotes Inflammation and Tumorigenesis in Mice and Human Gastric Neoplasia
Katsha, A. M., Soutto, M., Sehdev, V., Peng, D., Washington, M. K., Piazuelo, M. B., Tantawy, M. N., Manning, H. C., Lu, P., Shyr, Y., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.050 · Cited by 116
Vilgelm, A. E., Pawlikowski, J. S., Liu, Y., Hawkins, O. E., Davis, T. A., Smith, J., Weller, K. P., Horton, L. W., McClain, C. M., Ayers, G. D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2405 · Cited by 115
Kitagawa, M., & Lee, S. H. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00014 · Cited by 113
Suppression of the STK15 oncogenic activity requires a transactivation‐independent p53 function
Chen, S.-S., Chang, P., Cheng, Y., Tang, F., & Lin, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf409 · Cited by 112
Aurora-A Regulation of Nuclear Factor-κB Signaling by Phosphorylation of IκBα
Briassouli, P., Chan, F., Savage, K., Reis-Filho, J. S., & Linardopoulos, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2272 · Cited by 112
A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis
Schnepp, R. W., Khurana, P., Attiyeh, E. F., Raman, P., Chodosh, S., Oldridge, D. A., Gagliardi, M. E., Conkrite, K. L., Asgharzadeh, S., Seeger, R. C., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.012 · Cited by 112
Kretzner, L., Scuto, A., Dino, P. M., Kowolik, C. M., Wu, J., Ventura, P. B., Jove, R., Forman, S. J., Yen, Y., & Kirschbaum, M. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2259 · Cited by 107
Steeghs, N., Eskens, F. A. L. M., Gelderblom, H. A. J., Verweij, J., Nortier, J. W. R., Ouwerkerk, J., van Noort, C., Mariani, M., Spinelli, R., Carpinelli, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6655 · Cited by 106
Wan, X., Long, Z., Yan, M., Xu, J., Xia, L.-P., Liu, L., Zhao, Y., Huang, X.-F., Wang, X.-R., Zhu, X., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn176 · Cited by 106
Self-citationChromosome Instability Modulated by BMI1–AURKA Signaling Drives Progression in Head and Neck Cancer
Chou, C.-H., Yang, N.-K., Liu, T., Tai, S., Hsu, D. S., Chen, Y., Chen, Y.-J., Chang, C., Tzeng, C., & Yang, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2397 · Cited by 104
Self-citationSehdev, V., Peng, D., Soutto, M., Washington, M. K., Revetta, F. L., Ecsedy, J., Zaika, A. I., Rau, T. T., Schneider‐Stock, R., Belkhiri, A., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0623 · Cited by 101
Hook, K. E., Garza, S. J., Lira, M. E., Ching, K. A., Lee, N. V., Cao, J. Q., Yuan, J. T., Ye, J., Ozeck, M., Shi, S. T., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0184 · Cited by 98
Inhibition of Aurora A in response to DNA damage
Krystyniak, A., Garcı́a-Echeverrı́a, C., Prigent, C., & Ferrari, S. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209056 · Cited by 96
Rong, R., Jiang, L., Sheikh, M. S., & Huang, Y. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210575 · Cited by 96
Faisal, A., Vaughan, L. S., Bavetsias, V., Sun, C., Atrash, B., Avery, S., Jamin, Y., Robinson, S. P., Workman, P., Blagg, J., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0333 · Cited by 94
Cohen, R. B., Jones, S. F., Aggarwal, C., von Mehren, M., Cheng, J., Spigel, D. R., Greco, F. A., Mariani, M., Rocchetti, M., Ceruti, R., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1445 · Cited by 93
PF-03814735, an Orally Bioavailable Small Molecule Aurora Kinase Inhibitor for Cancer Therapy
Jani, J. P., Arcari, J. T., Bernardo, V., Bhattacharya, S. K., Briere, D. M., Cohen, B. D., Coleman, K. G., Christensen, J. G., Emerson, E. O., Jakowski, A. B., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0915 · Cited by 92
Chefetz, I., Holmberg, J. C., Alvero, A. B., Visintin, I., & Mor, G. (2011) · Cell Cycle · doi:10.4161/cc.10.13.16348 · Cited by 92
Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 – 2013)
Cheung, C. H. A., Sarvagalla, S., Lee, J. Y.-C., Huang, Y.-C., & Coumar, M. S. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.931374 · Cited by 91
Katayama, H. G., Wang, J., Treekitkarnmongkol, W., Kawai, H., Sasai, K., Zhang, H., Wang, H., Adams, H. P., Jiang, S., Chakraborty, S. N., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.025 · Cited by 91
Zhou, N., Singh, K., Mir, M. C., Parker, Y., Lindner, D. J., Dreicer, R., Ecsedy, J., Zhang, Z., Teh, B. T., Almasan, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2383 · Cited by 89
Takeshita, M., Koga, T., Takayama, K., Ijichi, K., Yano, T., Maehara, Y., Nakanishi, Y., & Sueishi, K. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2012.12.018 · Cited by 87
Qi, W., Cooke, L. S., Liu, X., Rimsza, L. M., Roe, D. J., Persky, A. M. D. O., Miller, T. P., & Mahadevan, D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.017 · Cited by 87
Xu, J., Wu, X., Zhou, W.-H., Liu, A.-W., Wu, J.-B., Deng, J.-Y., Yue, C.-F., Yang, S.-B., Wang, J., Yuan, Z.-Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056919 · Cited by 87
Self-citationAurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
Ali, H. R., Dawson, S.-J., Blows, F. M., Provenzano, E., Pd, P., & Caldas, C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.167 · Cited by 86
Aurora‐A over‐expression in high‐grade PIN lesions and prostate cancer
Buschhorn, H. M., Klein, R. R., Chambers, S. M., Hardy, M. C., Green, S., Bearss, D. J., & Nagle, R. B. (2005) · The Prostate · doi:10.1002/pros.20247 · Cited by 86
Traynor, A. M., Hewitt, M. R., Liu, G., Flaherty, K. T., Clark, J., Freedman, S. J., Scott, B. B., Leighton, A. M., Watson, P. A., Zhao, B., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1318-9 · Cited by 85
Siggelkow, W., Boehm, D. U., Gebhard, S., Battista, M. J., Sicking, I., Lebrecht, A., Solbach, C., Hellwig, B., Rahnenführer, J., Koelbl, H., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-562 · Cited by 83
VanderPorten, E. C., Taverna, P., Hogan, J. N., Ballinger, M. D., Flanagan, W. M., & Fucini, R. V. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0754 · Cited by 82
Marxer, M., Ma, H. T., Man, W. Y., & Poon, R. Y. C. (2013) · Oncogene · doi:10.1038/onc.2013.325 · Cited by 79
Aurora A kinase and its substrate TACC3 are required for central spindle assembly
Lioutas, A., & Vernos, I. (2013) · EMBO Reports · doi:10.1038/embor.2013.109 · Cited by 79
Dees, E. C., Infante, J. R., Cohen, R. B., O’Neil, B. H., Jones, S. F., von Mehren, M., Danaee, H., Lee, Y., Ecsedy, J., Manfredi, M. G., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1377-y · Cited by 78
Danusertib, an aurora kinase inhibitor
Meulenbeld, H. J., Mathijssen, R. H. J., Verweij, J., de Wit, R., & Jonge, M. J. D. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.652303 · Cited by 78
Goldberg, S. L., Fenaux, P., Craig, M., Gyan, E., LISTER, J. W., Kassis, J., Pigneux, A., Schiller, G. J., Jung, J., Leonard, E. J., et al. (2014) · Leukemia Research Reports · doi:10.1016/j.lrr.2014.06.003 · Cited by 78
p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation
Wu, C.-C., Yang, T., Yu, C. R., Phan, L. M., Ivan, C., Sood, A. K., Hsu, S., & Lee, M. (2012) · Cell Cycle · doi:10.4161/cc.21732 · Cited by 78
Dere, R., Perkins, A. L., Bawa‐Khalfe, T., Jonasch, D., & Walker, C. L. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090984 · Cited by 77
Gong, Y., Li, Y., Abdolmaleky, H. M., Li, L., & Zhou, J.-R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033656 · Cited by 76
Models of breast cancer: quo vadis, animal modeling?
Wagner, K. (2003) · Breast Cancer Research · doi:10.1186/bcr723 · Cited by 76
Aurora A is involved in central spindle assembly through phosphorylation of Ser 19 in P150Glued
Reboutier, D., Troadec, M., Crémet, J.-Y., Chauvin, L., Guen, V. J., Salaün, P., & Prigent, C. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201210060 · Cited by 74
Arbitrario, J. P., Belmont, B. J., Evanchik, M. J., Flanagan, W. M., Fucini, R. V., Hansen, S. K., Harris, S. O., Hashash, A., Hoch, U., Hogan, J. N., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1076-8 · Cited by 73
Tao, Y., Zhang, P., Frascogna, V., Lécluse, Y., Auperin, A., Bourhis, J., & Deutsch, É. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604083 · Cited by 72
Lehman, N. L., O’Donnell, J. P., Whiteley, L. J., Stapp, R., Lehman, T. D., Roszka, K. M., Schultz, L. R., Williams, C. J., Mikkelsen, T., Brown, S. L., et al. (2012) · Cell Cycle · doi:10.4161/cc.11.3.18996 · Cited by 71
Zheng, F.-M., Long, Z., Hou, Z.-J., Luo, Y., Xu, L.-Z., Xia, J.-L., Lai, X.-J., Liu, J.-W., Wang, X., Muhammad, K. I., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1029 · Cited by 71
Self-citationXu, J., Yue, C.-F., Zhou, W.-H., Qian, Y., Zhang, Y., Wang, S.-W., Liu, A.-W., & Liu, Q. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-200 · Cited by 70
Self-citationBenten, D., Keller, G., Quaas, A., Schrader, J., Gontarewicz, A., Balabanov, S., Braig, M., Wege, H., Moll, J. K., Lohse, A. W., et al. (2009) · Neoplasia · doi:10.1593/neo.09664 · Cited by 69
Aurora-A overexpression and aneuploidy predict poor outcome in serous ovarian carcinoma
Lassus, H. J., Staff, S. M., Leminen, A., Isola, J. J., & Bützow, R. C. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.09.003 · Cited by 68
Liu, L.-L., Long, Z., Wang, L.-X., Zheng, F.-M., Fang, Z.-G., Yan, M., Xu, D.-F., Chen, J.-J., Wang, S.-W., Lin, D.-J., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0172 · Cited by 68
Self-citationAurora-A gene is frequently amplified in basal-like breast cancer
Staff, S. M. (2009) · Oncology Reports · doi:10.3892/or_00000637 · Cited by 67
Iacono, M. L., Monica, V., Saviozzi, S., Ceppi, P., Bracco, E., Papotti, M. G., & Scagliotti, G. V. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-100 · Cited by 66
Giovinazzi, S., Morozov, V. M., Summers, M. K., Reinhold, W. C., & Ishov, A. M. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.169 · Cited by 65
AT9283, a novel aurora kinase inhibitor, suppresses tumor growth in aggressive B‐cell lymphomas
Qi, W., Liu, X., Cooke, L. S., Persky, D. O., Miller, T. P., Squires, M. S., & Mahadevan, D. (2011) · International Journal of Cancer · doi:10.1002/ijc.26324 · Cited by 65
Diamond, J. R., Bastos, B. R., Hansen, R. J., Gustafson, D. L., Eckhardt, S. G., Kwak, E. L., Pandya, S. S., Fletcher, G. C., Pitts, T. M., Kulikowski, G. N., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2144 · Cited by 65
Arkenau, H., Plummer, R., Molife, L. R., Olmos, D., Yap, T. A., Squires, M. S., Lewis, S., Lock, V., Yule, M., Lyons, J. F., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr451 · Cited by 65
Regan, J. L., Sourisseau, T., Soady, K., Kendrick, H. D., McCarthy, A., Tang, C., Brennan, K. R., Linardopoulos, S., White, D. E., & Smalley, M. J. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.05.044 · Cited by 64
Aurora kinases A and B and familial breast cancer risk
Tchatchou, S., Wirtenberger, M., Hemminki, K., Sutter, C., Meindl, A., Wappenschmidt, B., Kiechle, M. B., Bugert, P., Schmutzler, R. K., Bartram, C. R., et al. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.05.002 · Cited by 64
Aurora kinase targeting in lung cancer reduces KRAS-induced transformation
dos Santos, E. O., Carneiro-Lobo, T. C., Aoki, M. N., Levantini, E., & Bassères, D. S. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0494-6 · Cited by 64
Sehdev, V., Katsha, A. M., Ecsedy, J., Zaika, A. I., Belkhiri, A., & El-Rifai, W. M. (2012) · Cancer · doi:10.1002/cncr.27801 · Cited by 62
Santo, L., Hideshima, T., Cirstea, D., Bandi, M., Nelson, E., Gorgun, G., Rodig, S., Vallet, S., Pozzi, S., Patel, K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3012 · Cited by 61
Mahadevan, D., Stejskal, A., Cooke, L. S., Manziello, A., Morales, C., Persky, D. O., Fisher, R. I., Miller, T. P., & Qi, W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2413 · Cited by 60
Grover, A., Singh, R., Shandilya, A., Priyandoko, D., Agrawal, V., Bisaria, V. S., Wadhwa, R., Kaul, S. C., & Sundar, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030890 · Cited by 59
Schöffski, P., Jones, S. F., Dumez, H., Infante, J. R., Mieghem, E. V., Fowst, C., Gerletti, P., Xu, H., Jakubczak, J. L., English, P. A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.07.008 · Cited by 59
Rac1 and Aurora A regulate MCAK to polarize microtubule growth in migrating endothelial cells
Braun, A., Dang, K., Buslig, F., Baird, M. A., Davidson, M. W., Waterman, C. M., & Myers, K. A. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201401063 · Cited by 59
Burum‐Auensen, E., Angelis, P. M. D., Schjølberg, A. R., Kravik, K., Aure, M. H., & Clausen, O. P. F. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7077.2007 · Cited by 59
Kelly, K. R., Nawrocki, S. T., Espitia, C. M., Zhang, M., Yang, J. J., Padmanabhan, S., Ecsedy, J., Giles, F. J., & Carew, J. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27579 · Cited by 58
Bush, T. L., Payton, M. N., Heller, S., Chung, G., Hanestad, K., Rottman, J. B., Loberg, R. D., Friberg, G. R., Kendall, R. L., Saffran, D. C., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1178 · Cited by 57
Qi, W., Spier, C. M., Liu, X., Agarwal, A., Cooke, L. S., Persky, D. O., Chen, D., Miller, T. P., & Mahadevan, D. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.10.017 · Cited by 56
Aurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA repair networks
Sun, H., Wang, Y., Wang, Z., Meng, J., Qi, Z., & Yang, G. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.019 · Cited by 55
Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma
Savannah, K. J. B., Demicco, E. G., Lusby, K., Ghadimi, M. P., Belousov, R., Young, E. D., Zhang, Y., Huang, K.-L., Lazar, A. J., Hunt, K. K., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0436 · Cited by 55
Self-citationWang, X., Lu, N., Niu, B., Chen, X., Xie, J., & Cheng, N. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0416 · Cited by 55
BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by βTrCP1
Moustafa-Kamal, M., Gamache, I., Lü, Y., Li, S., & Teodoro, J. G. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.93 · Cited by 54
Ice, R. J., McLaughlin, S. L., Livengood, R. H., Culp, M. V., Eddy, E. R., Ivanov, A. V., & Pugacheva, E. N. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4008 · Cited by 54
Mannino, M., Gomez-Roman, N., Hochegger, H., & Chalmers, A. J. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.05.001 · Cited by 52
Schmidt, S., Schneider, L. X., Eßmann, F., Cirstea, I. C., Kuck, F., Kletke, A., Jänicke, R. U., Wiek, C., Hanenberg, H., Ahmadian, M. R., et al. (2010) · Oncogene · doi:10.1038/onc.2010.354 · Cited by 52
Twu, N.-F., Yuan, C., Yen, M.-S., Lai, C., Chao, K.-C., Wang, P., Wu, H.-H., & Chen, Y. (2008) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2008.09.012 · Cited by 51
Song, S. J., Song, M. S., Kim, S., Kim, S. Y., Kwon, S., Kim, J. G., Calvisi, D. F., Kang, D., & Lim, D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3984 · Cited by 50
Wang, X., Sinn, A. L., Pollok, K. E., Sandusky, G. E., Zhang, S., Chen, L., Liang, J., Crean, C., Suvannasankha, A., Abonour, R., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08248.x · Cited by 49
Tentler, J. J., Ionkina, A. A., Tan, A. C., Newton, T. P., Pitts, T. M., Glogowska, M. J., Kabos, P., Sartorius, C. A., Sullivan, K. D., Espinosa, J. M., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0538-t · Cited by 49
Chakravarty, A., Shinde, V., Tabernero, J. M., Cervantes, A. M. R., Cohen, R. B., Dees, E. C., Burris, H. A., Infante, J. R., Macarulla, T. M., Élez, E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1030 · Cited by 49
Konen, J. M., Wilkinson, S. C., Lee, B., Fu, H., Zhou, W., Jiang, Y., & Marcus, A. I. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-08-0569 · Cited by 49
Tomita, M., & Mori, N. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01499.x · Cited by 47
Yamamoto, S., Yamamoto‐Ibusuki, M., Yamamoto, Y., Fujiwara, S., & Iwase, H. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-217 · Cited by 45
Mahankali, M., Henkels, K. M., Speranza, F., et al. (2014) · Journal of Cell Science · doi:10.1242/jcs.157339 · Cited by 44
Diamond, J. R., Eckhardt, S. G., Tan, A. C., Newton, T. P., Selby, H. M., Brunkow, K. L., Kachaeva, M. I., Varella‐Garcia, M., Pitts, T. M., Bray, M. R., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1611 · Cited by 44
Aurora kinase inhibitor patents and agents in clinical testing: an update (2009 – 10)
Cheung, C. H. A., Coumar, M. S., Chang, J., & Hsieh, H. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.574614 · Cited by 43
Dotan, E., Meropol, N. J., Zhu, F., Zambito, F., Bove, B. A., Cai, K. Q., Godwin, A. K., Golemis, E. A., Astsaturov, I. A., & Cohen, S. J. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.587 · Cited by 42
Horwacik, I., Durbas, M., Boratyn, E., Węgrzyn, P., & Rokita, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.018 · Cited by 41
CD34+/CD38−acute myelogenous leukemia cells aberrantly express Aurora kinase A
Yang, J., Ikezoe, T., Nishioka, C., Nobumoto, A., Udaka, K., & Yokoyama, A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28277 · Cited by 39
Lin, Y., Richards, F. M., Krippendorff, B.-F., Bramhall, J. L., Harrington, J., Bapiro, T. E., Robertson, A. A. B., Zheleva, D. I., & Jodrell, D. I. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.450 · Cited by 39
Cui, S.-Y., Huang, J., Chen, Y., Song, H., Huang, G., De, W., Wang, R., & Chen, L. (2013) · Cell Cycle · doi:10.4161/cc.25916 · Cited by 38
Moretti, L., Niermann, K. J., Schleicher, S. M., Giacalone, N. J., Varki, V., Kim, K. W., Kopsombut, P., Jung, D. K., & Lü, B. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.01.060 · Cited by 37
Fraedrich, K., Schrader, J., Ittrich, H., Keller, G., Gontarewicz, A., Matzat, V., Kromminga, A., Pace, A., Moll, J. K., Bläker, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2968 · Cited by 37
Wu, C. C., Yu, C. R., Chang, G., Lai, J.-M., & Hsu, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.001 · Cited by 36
Ke, C.-S., Liu, H., Yen, C.-H., Huang, G.-C., Cheng, H.-C., Huang, C. F., & Su, C. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.01.003 · Cited by 36
Aurora Kinase Inhibition Induces PUMA via NF-κB to Kill Colon Cancer Cells
Sun, J., Knickelbein, K., He, K., Chen, D., Dudgeon, C., Shu, Y., Yu, J., & Zhang, L. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0846 · Cited by 36
Fei, F., Stoddart, S., Groffen, J., & Heisterkamp, N. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0069 · Cited by 36
Regulation of APC/CCdc20 activity by RASSF1A–APC/CCdc20 circuitry
Chow, C., Wong, N., Pagano, M., Lun, S. W.-M., Nakayama, K.-I., Nakayama, K., & Lo, K. W. (2011) · Oncogene · doi:10.1038/onc.2011.372 · Cited by 36
Xu, L.-Z., Long, Z., Peng, F., Liu, Y., Xu, J., Wang, C., Jiang, L., Guo, T., Muhammad, K. I., Li, S.-S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2241 · Cited by 35
Self-citationXu, H., Ma, L., Qi, F., Liu, Y., Yu, J., Dai, S., Zhu, J., & Wang, E. (2006) · Pathology International · doi:10.1111/j.1440-1827.2006.01974.x · Cited by 34
Mergen, M., Engel, C., Muller, B., Follo, M., Schafer, T., Jung, M., & Walz, G. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft316 · Cited by 33
Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death
Ratushny, V., Pathak, H. B., Beeharry, N., Tikhmyanova, N., Xiao, F., Li, T., Litwin, S., Connolly, D. C., Yen, T. J., Weiner, L. M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.314 · Cited by 33
de Oliveira, F. M., Lucena-Araujo, A. R., Favarin, M. D. C., Palma, P. V. B., Rego, E. M., Falcão, R. P., Covas, D. T., & Fontes, A. M. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.10.009 · Cited by 29
Fiskus, W. C., Hembruff, S. L., Rao, R., Sharma, P., Balusu, R., Venkannagari, S., Smith, J. E., Peth, K., Peiper, S. C., & Bhalla, K. N. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2171-9 · Cited by 29
Courapied, S., Cherier, J., Vigneron, A. M., Troadec, M., Giraud, S., Valo, I., Prigent, C., Gamelin, E. C., Coqueret, O., & Barré, B. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-205 · Cited by 29
Donato, N. J., Fang, D., Sun, H., Giannola, D. M., Peterson, L. F., & Talpaz, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.10.009 · Cited by 27
Li, N., Maly, D. J., Chanthery, Y. H., Sirkis, D. W., Nakamura, J. L., Berger, M. S., James, C. D., Shokat, K. M., Weiss, W. A., & Persson, A. I. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0526 · Cited by 27
Pan, J. Y.-J., Ajani, J. A., Gu, J. H., Gong, Y., Quin, A., Hung, M., Wu, X., & Izzo, J. G. (2011) · Cancer · doi:10.1002/cncr.26581 · Cited by 25
Chowdhury, A., Chowdhury, S., & Tsai, M. Y. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.619018 · Cited by 25
Cited by
Aurora kinases: novel therapy targets in cancers
Tang, A., Gao, K., Chu, L., Zhang, R., Yang, J., & Zheng, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14893 · Cited by 382
The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review
Liu, K., Zheng, M., Lu, R., Du, J., Zhao, Q., Li, Z., Li, Y., & Zhang, S. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01304-w · Cited by 287
Anticancer activity of complexes of the third row transition metals, rhenium, osmium, and iridium
Konkankit, C. C., Marker, S. C., Knopf, K. M., & Wilson, J. J. (2018) · Dalton Transactions · doi:10.1039/c8dt01858h · Cited by 284
Liao, M., Yao, D., Wu, L., Luo, C., Wang, Z., Zhang, J., & Liu, B. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.12.003 · Cited by 261
Self-citation
Metadata
- Authors
- Yan, M., Wang, C., He, B., Yang, M., Tong, M., Long, Z., Liu, B., Peng, F., Xu, L., Zhang, Y., Liang, D., Lei, H., Subrata, S., Kelley, K. W., Lam, E. W. ‐., Jin, B., & Liu, Q.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2016-07-13
- Volume
- 36
- Issue
- 6
- Pages
- 1036-1079
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2503725456
- Cited by
- 293
- References
- 210
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.